Mainstay Medical receives approval for ReActiv8 from Australian TGA

Ireland based medical device company Mainstay Medical International plc has announced that it has received regulatory ap...

December 11, 2019 | Wednesday | News
Novotech collaborates with PPC Group

Novotech and PPC Group (PPC), two leading, Asia-Pacific contract research organisations (CROs), have formed a strat...

December 3, 2019 | Tuesday | News
Vaccitech provides update for its Phase 2 Universal Influenza studies

Vaccitech Ltd, a clinical-stage T cell immunotherapy company developing products to treat and prevent cancer and infecti...

November 25, 2019 | Monday | News
Indian traditional medicine legacy reaches Australia

All India Institute of Ayurveda (AIIA) has signed a Memorandum of Understanding with Western Sydney University, Australi...

November 25, 2019 | Monday | News
Imagion Biosystems receives patent from India

Imagion Biosystems Limited, an Australian company dedicated to improving healthcare through the earlier detection of can...

November 14, 2019 | Thursday | News
Spectrum Therapeutics focuses on Real World Evidence research

Spectrum Therapeutics, the medical division of Canopy Growth Corporation (Canopy Growth), is pleased to announce an Aust...

November 12, 2019 | Tuesday | News
Icon Group expands footprint in Asia Pacific

Icon Group (Icon), Australia’s largest dedicated provider of cancer care has announced the completion of a debt ra...

November 11, 2019 | Monday | News
FIND Collaborates with SpeeDx and QuantuMDx

Australia based SpeeDx Pty. Ltd. and UK headquartered QuantuMDx Group Ltd. have announced a collaboration with the Found...

November 7, 2019 | Thursday | News
Icon Group expands cancer care capabilities

Icon Group, Australia's largest dedicated provider of cancer care, with a growing reach into New Zealand&...

November 4, 2019 | Monday | News
Mallinckrodt, Terumo BCT announce UVADEX approval in Australia

Mallinckrodt plc, a global biopharmaceutical company, and Terumo BCT, a global leader in blood component, therapeut...

November 1, 2019 | Friday | News
Kazia raises A$4.0 M to progress R&D programs

Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company, on 28 October 2019, announced that the...

October 29, 2019 | Tuesday | News
Fresenius Medical Care expands services in Western Australia

Fresenius Medical Care, the world's leading provider of dialysis products and services, has announced the further enhanc...

October 30, 2019 | Wednesday | News
World first clinical trial commences in alcohol use disorder

A medication currently used to treat insomnia may also be effective in preventing alcohol intake and relapse in alcohol ...

October 28, 2019 | Monday | News
Osteopore gets recognition for innovative healthcare product

Osteopore, an Australian medical device company that designs and manufactures regenerative implants made via 3D printing...

October 24, 2019 | Thursday | News
NeuClone announces First Human dose of Stelara® (Ustekinumab) Biosimilar candidate

NeuClone, a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products,...

October 21, 2019 | Monday | News
Celltrion, Juno establish biosimilar partnership

Celltrion Healthcare Australia (Celltrion) and Juno Pharmaceuticals (Juno) have entered in to a co-marketing partnership...

October 18, 2019 | Friday | News
Admedus inks $A36.2M deal for CardioCel And VascuCel Patch biz

Australia based Admedus Limited announces the sale of its CardioCel® and VascuCel® patch business to U...

October 15, 2019 | Tuesday | News
George Clinical names Sean Hart as Chief Business Officer

George Clinical, a global scientifically-driven clinical research organization (CRO) has announced the promotion of Sean...

October 14, 2019 | Monday | News